Akebia Therapeutics, Inc. financial data

Symbol
AKBA on Nasdaq
Industry
Pharmaceutical Preparations
Location
245 First Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 128 % -3.41%
Quick Ratio 23.6 % +9.85%
Debt-to-equity -804 % +80.9%
Return On Equity 123 % -89.8%
Return On Assets -17.5 % +40.4%
Operating Margin -20.2 % +54.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 210M shares
Common Stock, Shares, Outstanding 210M shares +11.6%
Entity Public Float 170M USD +165%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 210M shares +12.3%
Weighted Average Number of Shares Outstanding, Diluted 210M shares +12.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 174M USD -13.1%
Cost of Revenue 65.3M USD -10.6%
Research and Development Expense 40.6M USD -59.4%
Operating Income (Loss) -35.3M USD +60.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.58M USD +23.2%
Net Income (Loss) Attributable to Parent -40.4M USD +58.8%
Earnings Per Share, Basic -0.2 USD/shares +63%
Earnings Per Share, Diluted -0.2 USD/shares +62.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 39.5M USD -26.3%
Accounts Receivable, after Allowance for Credit Loss, Current 29.8M USD +52.1%
Inventory, Net 23.9M USD +14.2%
Other Assets, Current 7.33M USD
Assets, Current 112M USD -5.36%
Property, Plant and Equipment, Net 2.9M USD -34.5%
Operating Lease, Right-of-Use Asset 10.4M USD -28%
Intangible Assets, Net (Excluding Goodwill) 18M USD -66.7%
Goodwill 59M USD 0%
Other Assets, Noncurrent 17.8M USD +431%
Assets 220M USD -13.2%
Accounts Payable, Current 10.1M USD -14.2%
Employee-related Liabilities, Current 6.36M USD -3.31%
Accrued Liabilities, Current 53.9M USD -4.45%
Contract with Customer, Liability, Current 43.3M USD
Liabilities, Current 107M USD +16.4%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 6.3M USD -45.1%
Other Liabilities, Noncurrent 6.56M USD -61.7%
Liabilities 254M USD -9.47%
Accumulated Other Comprehensive Income (Loss), Net of Tax 6K USD 0%
Retained Earnings (Accumulated Deficit) -1.64B USD -2.54%
Stockholders' Equity Attributable to Parent -33.8M USD -25.9%
Liabilities and Equity 220M USD -13.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.4M USD -10.8%
Net Cash Provided by (Used in) Financing Activities 18.5M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 210M shares +11.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -957K USD +97.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 41.2M USD -25.5%
Deferred Tax Assets, Valuation Allowance 365M USD +1.31%
Deferred Tax Assets, Gross 377M USD -1.86%
Operating Lease, Liability 11.5M USD -29.3%
Depreciation 364K USD -8.54%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -40.4M USD +58.8%
Lessee, Operating Lease, Liability, to be Paid 12.3M USD -31.6%
Property, Plant and Equipment, Gross 14.5M USD +0.79%
Operating Lease, Liability, Current 5.18M USD +8.87%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.61M USD -37.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.82M USD +1.38%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 830K USD -53.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.61M USD -56.4%
Deferred Tax Assets, Operating Loss Carryforwards 289M USD +0.03%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.57M USD -60.9%
Operating Lease, Payments 5.6M USD -16.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 36M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 11.6M USD -50.4%
Share-based Payment Arrangement, Expense 7.77M USD -40.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%